| Mutations in Kir2. 1 cause the developmental and episodic electrical phenotypes of Andersen's syndrome NM Plaster, R Tawil, M Tristani-Firouzi, S Canún, S Bendahhou, ... Cell 105 (4), 511-519, 2001 | 1180 | 2001 |
| International consensus guidance for management of myasthenia gravis: executive summary DB Sanders, GI Wolfe, M Benatar, A Evoli, NE Gilhus, I Illa, N Kuntz, ... Neurology 87 (4), 419-425, 2016 | 984 | 2016 |
| Randomized trial of thymectomy in myasthenia gravis GI Wolfe, HJ Kaminski, IB Aban, G Minisman, HC Kuo, A Marx, P Ströbel, ... New England Journal of Medicine 375 (6), 511-522, 2016 | 891 | 2016 |
| A phase I/IItrial of MYO‐029 in adult subjects with muscular dystrophy KR Wagner, JL Fleckenstein, AA Amato, RJ Barohn, K Bushby, ... Annals of neurology 63 (5), 561-571, 2008 | 611 | 2008 |
| Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind … JF Howard, K Utsugisawa, M Benatar, H Murai, RJ Barohn, I Illa, S Jacob, ... The Lancet Neurology 16 (12), 976-986, 2017 | 586 | 2017 |
| Myasthenia gravis activities of daily living profile GI Wolfe, L Herbelin, SP Nations, B Foster, WW Bryan, RJ Barohn Neurology 52 (7), 1487-1487, 1999 | 451 | 1999 |
| Reliability Testing of the Quantitative Myasthenia Gravis Scorea RJ Barohn, D McINTIRE, L Herbelin, GI Wolfe, S Nations, WW Bryan Annals of the New York Academy of Sciences 841 (1), 769-772, 1998 | 392 | 1998 |
| International consensus guidance for management of myasthenia gravis: 2020 update P Narayanaswami, DB Sanders, G Wolfe, M Benatar, G Cea, A Evoli, ... Neurology 96 (3), 114-122, 2021 | 377 | 2021 |
| Static magnetic field therapy for symptomatic diabetic neuropathy: a randomized, double-blind, placebo-controlled trial MI Weintraub, GI Wolfe, RA Barohn, SP Cole, GJ Parry, G Hayat, ... Archives of physical medicine and rehabilitation 84 (5), 736-746, 2003 | 326 | 2003 |
| Multifocal acquired demyelinating sensory and motor neuropathy: the Lewis–Sumner syndrome DS Saperstein, AA Amato, GI Wolfe, JS Katz, SP Nations, CE Jackson, ... Muscle & Nerve: Official Journal of the American Association of …, 1999 | 305 | 1999 |
| Evaluation of neurologic function in Gulf War veterans: a blinded case-control study RW Haley, J Hom, PS Roland, WW Bryan, PC Van Ness, FJ Bonte, ... Jama 277 (3), 223-230, 1997 | 282 | 1997 |
| Inclusion body myositis: clinical and pathological boundaries AA Amato, GS Gronseth, CE Jackson, GI Wolfe, JS Katz, WW Bryan, ... Annals of Neurology: Official Journal of the American Neurological …, 1996 | 249 | 1996 |
| Denture cream: an unusual source of excess zinc, leading to hypocupremia and neurologic disease SP Nations, PJ Boyer, LA Love, MF Burritt, JA Butz, GI Wolfe, LS Hynan, ... Neurology 71 (9), 639-643, 2008 | 244 | 2008 |
| Isolated neck extensor myopathy: a common cause of dropped head syndrome JS Katz, GI Wolfe, DK Burns, WW Bryan, JL Fleckenstein, RJ Barohn Neurology 46 (4), 917-921, 1996 | 239 | 1996 |
| Consensus treatment recommendations for late‐onset Pompe disease EJ Cupler, KI Berger, RT Leshner, GI Wolfe, JJ Han, RJ Barohn, JT Kissel, ... Muscle & nerve 45 (3), 319-333, 2012 | 234 | 2012 |
| 2016 American College of Rheumatology/European League Against Rheumatism criteria for minimal, moderate, and major clinical response in adult dermatomyositis and polymyositis … R Aggarwal, LG Rider, N Ruperto, N Bayat, B Erman, BM Feldman, ... Arthritis & Rheumatology 69 (5), 898-910, 2017 | 225 | 2017 |
| Clinical findings in MuSK‐antibody positive myasthenia gravis: a US experience M Pasnoor, GI Wolfe, S Nations, J Trivedi, RJ Barohn, L Herbelin, ... Muscle & Nerve: Official Journal of the American Association of …, 2010 | 208 | 2010 |
| Brachial amyotrophic diplegia: a slowly progressive motor neuron disorder JS Katz, GI Wolfe, PB Andersson, DS Saperstein, JL Elliott, SP Nations, ... Neurology 53 (5), 1071-1071, 1999 | 194 | 1999 |
| Electrophysiologic findings in multifocal motor neuropathy JS Katz, GI Wolfe, WW Bryan, CE Jackson, AA Amato, RJ Barohn Neurology 48 (3), 700-707, 1997 | 191 | 1997 |
| Long‐term safety and efficacy of eculizumab in generalized myasthenia gravis S Muppidi, K Utsugisawa, M Benatar, H Murai, RJ Barohn, I Illa, S Jacob, ... Muscle & nerve 60 (1), 14-24, 2019 | 186 | 2019 |
